TScan Therapeutics, Inc. shares its quarterly performance and updates in a recent filing, showcasing its commitment to advancing biological products.
| Name | TScan Therapeutics, Inc. |
|---|---|
| CIK | 0001783328 |
| Tickers | TCRX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 825282075 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 857-399-9500 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
TScan Therapeutics, Inc. shares its quarterly performance and updates in a recent filing, showcasing its commitment to advancing biological products.
TScan Therapeutics announces its third-quarter financial results, reflecting progress in the biological products sector.
TScan Therapeutics has filed a definitive proxy statement, outlining key decisions for its upcoming shareholder meeting, impacting corporate governance and strategy.
336 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-456919 | 001-40603 | 261543155 | 34 | 7827264 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-456865 | 001-40603 | 261543030 | 34 | 411234 | 1 | 1 |
| 2026-10-26 | DEF 14A | DEF 14A | 0001193125-26-431045 | 001-40603 | 261483587 | 34 | 610358 | |||
| 2026-10-16 | PRE 14A | PRE 14A | 0001193125-26-424240 | 001-40603 | 261466848 | 34 | 600642 | |||
| 2026-10-16 | 8-K | 8-K | 5.02 | 0001193125-26-424198 | 001-40603 | 261466676 | 34 | 138546 | 1 | 1 |
| 2026-10-02 | 4 | 4 | 0001193125-26-412521 | 5004 | ||||||
| 2026-10-02 | 4 | 4 | 0001193125-26-412518 | 5034 | ||||||
| 2026-09-30 | 8-K | 8-K | 5.02 | 0001193125-26-409199 | 001-40603 | 261427813 | 34 | 140916 | 1 | 1 |
| 2026-09-25 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002063423-26-000002 | 005-92700 | 261410516 | 34 | 15139 | |||
| 2026-09-11 | 8-K | 8-K | 5.02 | 0001193125-26-388631 | 001-40603 | 261372713 | 34 | 143600 | 1 | 1 |
| 2026-09-02 | 8-K | 8-K | 2.05,3.01,5.02,7.01,8.01,9.01 | 0001193125-26-379343 | 001-40603 | 261352639 | 34 | 2714969 | 1 | 1 |
| 2026-08-18 | 8-K | 8-K | 1.02 | 0001193125-26-355664 | 001-40603 | 261291731 | 34 | 141042 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-003526 | 005-92700 | 261282728 | 34 | 10608 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002183 | 005-92700 | 261282118 | 34 | 25556 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-345749 | 001-40603 | 261265328 | 34 | 7761071 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-345732 | 001-40603 | 261265304 | 34 | 430637 | 1 | 1 |
| 2026-06-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-276693 | 001-40603 | 261104887 | 34 | 7419514 | 1 | 1 |
| 2026-05-22 | 4 | 4 | 0001193125-26-236870 | 22565 | ||||||
| 2026-05-22 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-26-236862 | 001-40603 | 261013699 | 34 | 170307 | 1 | 1 |
| 2026-05-22 | 4 | 4 | 0001193125-26-236855 | 5411 | ||||||
| 2026-05-22 | 4 | 4 | 0001193125-26-236854 | 5411 | ||||||
| 2026-05-22 | 4 | 4 | 0001193125-26-236848 | 5404 | ||||||
| 2026-05-22 | 4 | 4 | 0001193125-26-236844 | 5398 | ||||||
| 2026-05-22 | 4 | 4 | 0001193125-26-236841 | 5401 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001399 | 005-92700 | 26987540 | 34 | 25388 | |||
| 2026-05-06 | 10-Q | 10-Q | 0001193125-26-207572 | 001-40603 | 26945823 | 34 | 6701513 | 1 | 1 | |
| 2026-05-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-207549 | 001-40603 | 26945797 | 34 | 442150 | 1 | 1 |
| 2026-04-17 | ARS | ARS | 0001193125-26-160310 | 001-40603 | 26869398 | 34 | 4562301 | |||
| 2026-04-17 | DEF 14A | DEF 14A | 0001193125-26-160304 | 001-40603 | 26869394 | 34 | 849888 | 1 | 1 | |
| 2026-04-07 | PRE 14A | PRE 14A | 0001193125-26-145614 | 001-40603 | 26845331 | 34 | 850119 | 1 | 1 | |
| 2026-04-02 | 8-K | 8-K | 5.02 | 0001193125-26-138973 | 001-40603 | 26830624 | 34 | 137843 | 1 | 1 |
| 2026-03-04 | S-8 | S-8 | 0001193125-26-089915 | 333-293989 | 26718865 | 33 | 184036 | 1 | 1 | |
| 2026-03-04 | 10-K | 10-K | 0001193125-26-089884 | 001-40603 | 26718855 | 34 | 15368557 | 1 | 1 | |
| 2026-03-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-089871 | 001-40603 | 26718841 | 34 | 394992 | 1 | 1 |
| 2026-01-22 | 4 | 4 | 0001193125-26-019729 | 5368 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-019723 | 20576 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-019702 | 5478 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-019697 | 5409 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-019674 | 19868 | ||||||
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-009771 | 001-40603 | 26524667 | 34 | 4515454 | 1 | 1 |
| 2025-12-23 | 4 | xslF345X05/ownership.xml | 0000902664-25-005396 | 11729 | ||||||
| 2025-11-26 | 8-K | 8-K | 5.02 | 0001193125-25-300538 | 001-40603 | 251530428 | 34 | 142249 | 1 | 1 |
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-275933 | 001-40603 | 251468850 | 34 | 7629742 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-275889 | 001-40603 | 251468774 | 34 | 367473 | 1 | 1 |
| 2025-11-03 | 8-K | 8-K | 2.05,7.01,8.01,9.01 | 0001193125-25-261612 | 001-40603 | 251442035 | 34 | 784579 | 1 | 1 |
| 2025-09-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-198768 | 001-40603 | 251301631 | 34 | 15231326 | 1 | 1 |
| 2025-08-22 | 3 | 3 | 0001193125-25-186427 | 28289 | ||||||
| 2025-08-20 | 8-K | 8-K | 5.02 | 0001193125-25-184083 | 001-40603 | 251236898 | 34 | 140230 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003579 | 005-92700 | 251214256 | 34 | 10330 | |||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003515 | 005-92700 | 251204590 | 34 | 13007 | |||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-106919 | 001-40603 | 251204029 | 34 | 7624697 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-106915 | 001-40603 | 251204008 | 34 | 424908 | 1 | 1 |
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002518 | 005-92700 | 251128494 | 34 | 10739 | |||
| 2025-07-02 | 4 | 4 | 0000950170-25-093232 | 22069 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-093058 | 19246 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-093057 | 5270 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-093047 | 5273 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-093021 | 19240 | ||||||
| 2025-07-02 | 4 | 4 | 0000950170-25-093020 | 19398 | ||||||
| 2025-07-02 | 8-K | 8-K | 5.07 | 0001193125-25-154336 | 001-40603 | 251098311 | 34 | 144167 | 1 | 1 |
| 2025-05-21 | 4 | xslF345X05/ownership.xml | 0000902664-25-002511 | 8948 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001553 | 005-92700 | 25954481 | 34 | 25530 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000367 | 005-92700 | 25951413 | 34 | 15891 | |||
| 2025-05-14 | ARS | ARS | 0001193125-25-119385 | 001-40603 | 25942623 | 34 | 2256129 | |||
| 2025-05-14 | DEFA14A | DEFA14A | 0001193125-25-119381 | 001-40603 | 25942600 | 34 | 629653 | |||
| 2025-05-14 | DEF 14A | DEF 14A | 0001193125-25-119378 | 001-40603 | 25942591 | 34 | 1271921 | 1 | 1 | |
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-063968 | 001-40603 | 25915245 | 34 | 6598910 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063959 | 001-40603 | 25915218 | 34 | 443831 | 1 | 1 |
| 2025-04-24 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001561 | 005-92700 | 25863910 | 34 | 10744 | |||
| 2025-03-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000693 | 333-285570 | 25742156 | 33 | 1729 | ||
| 2025-03-12 | CORRESP | filename1.htm | 0001193125-25-052682 | 5983 | ||||||
| 2025-03-11 | UPLOAD | filename1.pdf | 0000000000-25-002674 | 333-285570 | 40044 | |||||
| 2025-03-05 | S-8 | S-8 | 0001193125-25-047221 | 333-285571 | 25711574 | 33 | 70023 | |||
| 2025-03-05 | S-3 | S-3 | 0001193125-25-047159 | 333-285570 | 25711526 | 33 | 994807 | |||
| 2025-03-05 | 10-K | 10-K | 0000950170-25-033077 | 001-40603 | 25708868 | 34 | 20122055 | 1 | 1 | |
| 2025-03-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-033071 | 001-40603 | 25708814 | 34 | 489735 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000905148-25-000661 | 005-92700 | 25629819 | 34 | 15504 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000979 | 005-92700 | 25623695 | 34 | 10392 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000872 | 005-92700 | 25612661 | 34 | 14285 | |||
| 2025-02-11 | 4 | 4 | 0000950170-25-018131 | 7723 | ||||||
| 2025-02-11 | 4 | 4 | 0000950170-25-018130 | 5386 | ||||||
| 2025-02-11 | 4 | 4 | 0000950170-25-018125 | 7674 | ||||||
| 2025-02-11 | 4 | 4 | 0000950170-25-018120 | 5299 | ||||||
| 2025-02-11 | 4 | 4 | 0000950170-25-018119 | 5361 | ||||||
| 2024-12-30 | 4 | xslF345X05/ownership.xml | 0000902664-24-007064 | 8668 | ||||||
| 2024-12-26 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-284671 | 001-40603 | 241576188 | 34 | 422420 | 1 | 1 |
| 2024-12-26 | 424B5 | 424B5 | 0001193125-24-284669 | 333-268260 | 241576084 | 33 | 683242 | |||
| 2024-12-23 | 8-K | 8-K | 1.01,1.02,2.03,7.01,9.01 | 0001193125-24-283673 | 001-40603 | 241569873 | 34 | 561586 | 1 | 1 |
| 2024-12-16 | 4 | xslF345X05/ownership.xml | 0000902664-24-006934 | 9979 | ||||||
| 2024-12-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-273985 | 001-40603 | 241537185 | 34 | 5626328 | 1 | 1 |
| 2024-11-21 | 8-K | FORM 8-K | 3.02 | 0000950142-24-002817 | 001-40603 | 241482217 | 34 | 197744 | 1 | 1 |
| 2024-11-19 | 4 | xslF345X05/ownership.xml | 0000902664-24-006718 | 7783 | ||||||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0000921895-24-002738 | 005-92700 | 241463529 | 34 | 278342 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001140361-24-046894 | 005-92700 | 241461900 | 34 | 122076 | |||
| 2024-11-14 | SC 13G/A | cormorant-tcrx093024a1.htm | 0001172661-24-005052 | 005-92700 | 241460762 | 34 | 87645 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-124575 | 001-40603 | 241443307 | 34 | 6069548 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-124558 | 001-40603 | 241443245 | 34 | 346193 | 1 | 1 |
| 2024-11-08 | SC 13G | us89854m1018_110824.txt | 0002012383-24-003685 | 005-92700 | 241439799 | 34 | 13692 | |||
| 2024-11-01 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-249124 | 001-40603 | 241417007 | 34 | 149716 | 1 | 1 |
| 2024-10-21 | SC 13G | us89854m1018_102124.txt | 0002012383-24-000954 | 005-92700 | 241383590 | 34 | 13680 | |||
| 2024-09-24 | 4 | 4 | 0000950170-24-109133 | 5541 | ||||||
| 2024-08-27 | 4 | 4 | 0000950170-24-101166 | 6972 | ||||||
| 2024-08-27 | 4 | 4 | 0000950170-24-101161 | 20455 | ||||||
| 2024-08-23 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001224 | 001-40603 | 241237390 | 33 | 4701 | |||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095066 | 001-40603 | 241194751 | 34 | 6064200 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095063 | 001-40603 | 241194726 | 34 | 336136 | 1 | 1 |
| 2024-06-14 | 4 | 4 | 0000950170-24-073696 | 5280 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073695 | 5247 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073694 | 5268 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073693 | 5254 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073692 | 7606 | ||||||
| 2024-06-14 | 3 | 3 | 0000950170-24-073670 | 16839 | ||||||
| 2024-06-14 | 4 | 4 | 0000950170-24-073658 | 22076 | ||||||
| 2024-06-14 | S-8 | FORM S-8 | 0001193125-24-161589 | 333-280212 | 241044709 | 33 | 69763 | |||
| 2024-06-14 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-161151 | 001-40603 | 241043137 | 34 | 326109 | 1 | 1 |
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058198 | 001-40603 | 24936878 | 34 | 5513803 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-058194 | 001-40603 | 24936858 | 34 | 343285 | 1 | 1 |
| 2024-05-03 | 4 | 4 | 0000950170-24-052872 | 5362 | ||||||
| 2024-05-02 | 3 | 3 | 0000950170-24-052061 | 13387 | ||||||
| 2024-04-30 | ARS | ARS | 0001193125-24-125141 | 001-40603 | 24897410 | 34 | 1796940 | |||
| 2024-04-30 | DEFA14A | DEFA14A | 0001193125-24-125079 | 001-40603 | 24897275 | 34 | 742906 | |||
| 2024-04-30 | DEF 14A | DEF 14A | 0001193125-24-125066 | 001-40603 | 24897177 | 34 | 924739 | |||
| 2024-04-29 | SC 13G | sc13g.htm | 0000929638-24-001648 | 005-92700 | 24890496 | 34 | 99518 | |||
| 2024-04-23 | SC 13D/A | SC 13D/A | 0001104659-24-050607 | 005-92700 | 24865144 | 34 | 99253 | |||
| 2024-04-23 | 4 | 4 | 0000950170-24-046916 | 20897 | ||||||
| 2024-04-23 | 4 | xslF345X05/ownership.xml | 0000902664-24-003030 | 8642 | ||||||
| 2024-04-18 | 424B5 | 424B5 | 0001193125-24-099491 | 333-277699 | 24852674 | 33 | 652027 | |||
| 2024-04-17 | 8-K | 8-K | 1.01,2.02,8.01,9.01 | 0001193125-24-098509 | 001-40603 | 24849333 | 34 | 614653 | 1 | 1 |
| 2024-04-17 | FWP | FWP | 0001193125-24-098504 | 333-277699 | 24849330 | 34 | 14878 | |||
| 2024-04-16 | 424B5 | 424B5 | 0001193125-24-097937 | 333-277699 | 24848751 | 33 | 649627 | |||
| 2024-04-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-097764 | 001-40603 | 24848018 | 34 | 17259142 | 1 | 1 |
| 2024-04-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-12 09:00:00 | 9999999995-24-000956 | 333-277699 | 24843000 | 33 | 1729 | ||
| 2024-04-10 | CORRESP | filename1.htm | 0001193125-24-091404 | 6249 | ||||||
| 2024-04-10 | 10-K/A | 10-K/A | 0001193125-24-091386 | 001-40603 | 24834256 | 34 | 621528 | 1 | 1 | |
| 2024-04-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-089164 | 001-40603 | 24828226 | 34 | 171830 | 1 | 1 |
| 2024-03-07 | UPLOAD | filename1.pdf | 0000000000-24-002553 | 333-277699 | 40278 | |||||
| 2024-03-06 | S-3 | S-3 | 0001193125-24-060718 | 333-277699 | 24725978 | 33 | 1038536 | |||
| 2024-03-06 | S-8 | S-8 | 0001193125-24-060705 | 333-277695 | 24725865 | 33 | 70876 | |||
| 2024-03-06 | 10-K | 10-K | 0000950170-24-026875 | 001-40603 | 24724376 | 34 | 12159361 | 1 | 1 | |
| 2024-03-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-026868 | 001-40603 | 24724361 | 34 | 364838 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001140361-24-008030 | 005-92700 | 24639635 | 34 | 118750 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001104659-24-012937 | 005-92700 | 24614869 | 34 | 189423 | |||
| 2024-02-08 | SC 13G/A | SC 13G/A | 0001104659-24-011824 | 005-92700 | 24606694 | 34 | 105363 | |||
| 2024-02-07 | SC 13G/A | TSCAN THERAPEUTICS, INC. | 0000902664-24-001174 | 005-92700 | 24602194 | 34 | 94366 | |||
| 2024-02-02 | 4 | 4 | 0000950170-24-010522 | 5323 | ||||||
| 2024-02-02 | 3 | 3 | 0000950170-24-010500 | 14149 | ||||||
| 2024-01-29 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-017379 | 001-40603 | 24570080 | 34 | 178900 | 1 | 1 |
| 2023-12-21 | 4 | 4 | 0000950170-23-072291 | 7402 | ||||||
| 2023-12-18 | 4 | 4 | 0000950170-23-071208 | 5541 | ||||||
| 2023-12-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-292080 | 001-40603 | 231476949 | 34 | 3505208 | 1 | 1 |
| 2023-12-08 | 4 | 4 | 0000950170-23-068925 | 5201 | ||||||
| 2023-12-08 | 3 | 3 | 0000950170-23-068924 | 15483 | ||||||
| 2023-12-07 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-290309 | 001-40603 | 231471066 | 34 | 170776 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-061533 | 001-40603 | 231390068 | 34 | 6336602 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061525 | 001-40603 | 231390043 | 34 | 362579 | 1 | 1 |
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-040961 | 001-40603 | 231157185 | 34 | 7433975 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-040954 | 001-40603 | 231157167 | 34 | 387747 | 1 | 1 |
| 2023-07-25 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-192484 | 001-40603 | 231106118 | 34 | 150056 | 1 | 1 |
| 2023-07-24 | 4 | 4 | 0000950170-23-034156 | 5255 | ||||||
| 2023-07-24 | 3 | 3 | 0000950170-23-034147 | 8072 | ||||||
| 2023-06-29 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-178075 | 001-40603 | 231054398 | 34 | 173189 | 1 | 1 |
| 2023-06-16 | S-8 | S-8 | 0001193125-23-169052 | 333-272733 | 231021822 | 33 | 60859 | |||
| 2023-06-16 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-168118 | 001-40603 | 231018658 | 34 | 172742 | 1 | 1 |
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015646 | 5420 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015644 | 6043 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015642 | 5393 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015640 | 5400 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015639 | 5530 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015636 | 6050 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015635 | 6047 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-015632 | 6046 | ||||||
| 2023-06-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-037371 | 22147 | ||||||
| 2023-06-12 | SC 13G | TSCAN THERAPEUTICS, INC. | 0000902664-23-003533 | 005-92700 | 231008518 | 34 | 106899 | |||
| 2023-06-08 | SC 13G/A | us89854m1018_060623.txt | 0001306550-23-009221 | 005-92700 | 231001419 | 34 | 12229 | |||
| 2023-06-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-014618 | 6390 | ||||||
| 2023-06-05 | SC 13G | SCHEDULE 13G | 0000921895-23-001429 | 005-92700 | 23993228 | 34 | 288522 | |||
| 2023-06-05 | SC 13G | tscan.htm | 0000935836-23-000439 | 005-92700 | 23992546 | 34 | 47323 | |||
| 2023-06-05 | 3 | xslF345X02/ownership.xml | 0000935836-23-000438 | 5046 | ||||||
| 2023-06-02 | 4 | xslF345X04/ownership.xml | 0000902664-23-003407 | 10466 | ||||||
| 2023-06-02 | 3 | xslF345X02/ownership.xml | 0000902664-23-003406 | 6211 | ||||||
| 2023-06-02 | SC 13G | TSCAN THERAPEUTICS, INC.. | 0000902664-23-003397 | 005-92700 | 23989844 | 34 | 68702 | |||
| 2023-06-02 | SC 13D/A | SC 13D/A | 0001104659-23-067540 | 005-92700 | 23988681 | 34 | 91734 | |||
| 2023-06-02 | DEFA14A | DEFA14A | 0001193125-23-159826 | 001-40603 | 23988671 | 34 | 596151 | |||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033647 | 21099 | ||||||
| 2023-05-31 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-157307 | 001-40603 | 23979030 | 34 | 572697 | 1 | 1 |
| 2023-05-31 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-157286 | 001-40603 | 23978995 | 34 | 172745 | 1 | 1 |
| 2023-05-30 | 424B5 | 424B5 | 0001193125-23-155650 | 333-268260 | 23971124 | 33 | 685039 | |||
| 2023-05-26 | FWP | FWP | 0001193125-23-154726 | 333-268260 | 23962989 | 34 | 15093 | |||
| 2023-05-25 | 424B5 | 424B5 | 0001193125-23-154339 | 333-268260 | 23961768 | 33 | 704239 | |||
| 2023-05-17 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-146584 | 001-40603 | 23929686 | 34 | 188278 | 1 | 1 |
| 2023-05-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-16 16:00:00 | 9999999995-23-001449 | 333-268261 | 23929558 | 33 | 1680 | ||
| 2023-05-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-16 16:00:00 | 9999999995-23-001448 | 333-268260 | 23929557 | 33 | 1680 | ||
| 2023-05-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-146203 | 001-40603 | 23928744 | 34 | 390588 | 1 | 1 |
| 2023-05-16 | 424B5 | 424B5 | 0001193125-23-146200 | 333-268260 | 23928727 | 33 | 584012 | |||
| 2023-05-16 | AW | AW | 0001193125-23-145915 | 333-268260 | 23926536 | NE | 7303 | |||
| 2023-05-16 | S-3/A | S-3/A | 0001193125-23-145297 | 333-268261 | 23925036 | 33 | 62441 | |||
| 2023-05-16 | S-3/A | S-3/A | 0001193125-23-145261 | 333-268260 | 23924845 | 33 | 62441 | |||
| 2023-05-16 | S-3/A | S-3/A | 0001193125-23-145259 | 333-268260 | 23924824 | 33 | 65032 | |||
| 2023-05-15 | CORRESP | filename1.htm | 0001193125-23-145273 | 5951 | ||||||
| 2023-05-15 | CORRESP | filename1.htm | 0001193125-23-145270 | 5951 | ||||||
| 2023-05-15 | 144 | xsl144X01/primary_doc.xml | 0001949846-23-000080 | 001-40603 | 23923500 | 33 | 5125 | |||
| 2023-05-10 | CORRESP | filename1.htm | 0001193125-23-140850 | 5815 | ||||||
| 2023-05-10 | CORRESP | filename1.htm | 0001193125-23-140844 | 5815 | ||||||
| 2023-05-10 | 10-Q | 10-Q | 0000950170-23-020087 | 001-40603 | 23904347 | 34 | 5664640 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020082 | 001-40603 | 23904323 | 34 | 397768 | 1 | 1 |
| 2023-05-09 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-23-139057 | 001-40603 | 23900265 | 34 | 203075 | 1 | 1 |
| 2023-04-25 | ARS | ARS | 0001193125-23-114191 | 001-40603 | 23841802 | 34 | 14982893 | |||
| 2023-04-25 | DEFA14A | DEFA14A | 0001193125-23-114151 | 001-40603 | 23841775 | 34 | 855745 | |||
| 2023-04-25 | DEF 14A | DEF 14A | 0001193125-23-114116 | 001-40603 | 23841759 | 34 | 807382 | |||
| 2023-04-10 | 4 | FORM 4 SUBMISSION | 0000899243-23-010999 | 5358 | ||||||
| 2023-04-10 | 3 | FORM 3 SUBMISSION | 0000899243-23-010996 | 4691 | ||||||
| 2023-04-10 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-095838 | 001-40603 | 23809721 | 34 | 180802 | 1 | 1 |
| 2023-03-31 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-086922 | 001-40603 | 23783518 | 34 | 183753 | 1 | 1 |
| 2023-03-08 | S-8 | S-8 | 0001193125-23-063834 | 333-270343 | 23714889 | 33 | 66890 | |||
| 2023-03-08 | 10-K | 10-K | 0000950170-23-006589 | 001-40603 | 23714875 | 34 | 13719596 | 1 | 1 | |
| 2023-03-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-006586 | 001-40603 | 23714862 | 34 | 457343 | 1 | 1 |
| 2023-02-14 | SC 13G/A | TSCAN THERAPEUTICS, INC. | 0000902664-23-001811 | 005-92700 | 23629295 | 34 | 46882 | |||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004063 | 5446 | ||||||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004062 | 5443 | ||||||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004064 | 5418 | ||||||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0000899243-23-004061 | 5413 | ||||||
| 2023-02-03 | SC 13G/A | us89854m1018_020323.txt | 0001306550-23-007802 | 005-92700 | 23586345 | 34 | 12949 | |||
| 2023-01-23 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-012556 | 001-40603 | 23542500 | 34 | 174184 | 1 | 1 |
| 2022-12-29 | 4 | FORM 4 SUBMISSION | 0000899243-22-039506 | 6842 | ||||||
| 2022-11-15 | UPLOAD | filename1.pdf | 0000000000-22-012378 | 40223 | ||||||
| 2022-11-15 | UPLOAD | filename1.pdf | 0000000000-22-012377 | 40227 | ||||||
| 2022-11-09 | S-3 | S-3 | 0001193125-22-280728 | 333-268261 | 221370703 | 33 | 355865 | |||
| 2022-11-09 | S-3 | S-3 | 0001193125-22-280725 | 333-268260 | 221370701 | 33 | 1062336 | |||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023507 | 001-40603 | 221370640 | 34 | 6679449 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023503 | 001-40603 | 221370621 | 34 | 484986 | 1 | 1 |
| 2022-09-30 | SC 13G | SC 13G | 0001140361-22-035533 | 005-92700 | 221285003 | 34 | 117075 | |||
| 2022-09-12 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0001193125-22-242437 | 001-40603 | 221237391 | 34 | 961579 | 1 | 1 |
| 2022-08-15 | SC 13G/A | SC 13G/A | 0001104659-22-091307 | 005-92700 | 221166644 | 34 | 79850 | |||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016263 | 001-40603 | 221150443 | 34 | 5775081 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016253 | 001-40603 | 221150381 | 34 | 358882 | 1 | 1 |
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-026849 | 5443 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-026848 | 5425 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-026847 | 5416 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-026846 | 5423 | ||||||
| 2022-07-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-026844 | 5444 | ||||||
| 2022-07-07 | 4 | FORM 4 SUBMISSION | 0000899243-22-025626 | 5450 | ||||||
| 2022-07-07 | 3 | FORM 3 SUBMISSION | 0000899243-22-025624 | 2901 | ||||||
| 2022-07-07 | 8-K | 8-K | 5.02 | 0001193125-22-189000 | 001-40603 | 221070632 | 34 | 147826 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034093 | 17142 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020963 | 5356 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020964 | 5383 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020965 | 5363 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020961 | 5354 | ||||||
| 2022-06-03 | 8-K | 8-K | 5.02,5.07 | 0001193125-22-167299 | 001-40603 | 22994269 | 34 | 151919 | 1 | 1 |
| 2022-05-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-163006 | 001-40603 | 22980421 | 34 | 170563 | 1 | 1 |
| 2022-05-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-019018 | 7132 | ||||||
| 2022-05-12 | SC 13D/A | SC 13D/A | 0001104659-22-059502 | 005-92700 | 22918587 | 34 | 91321 | |||
| 2022-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-028579 | 30531 | ||||||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009472 | 001-40603 | 22915772 | 34 | 5247640 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008234 | 001-40603 | 22903219 | 34 | 327356 | 1 | 1 |
| 2022-04-21 | DEFA14A | DEFA14A | 0001193125-22-112145 | 001-40603 | 22839717 | 34 | 577866 | |||
| 2022-04-21 | DEF 14A | DEF 14A | 0001193125-22-112138 | 001-40603 | 22839700 | 34 | 787347 | |||
| 2022-03-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-012476 | 5061 | ||||||
| 2022-03-09 | S-8 | S-8 | 0001193125-22-069921 | 333-263380 | 22723933 | 33 | 62122 | |||
| 2022-03-09 | 10-K | 10-K | 0000950170-22-003175 | 001-40603 | 22723914 | 34 | 12973005 | 1 | 1 | |
| 2022-03-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-069875 | 001-40603 | 22723894 | 34 | 208374 | 1 | 1 |
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-042256 | 005-92700 | 22635079 | 34 | 102137 | |||
| 2022-02-14 | SC 13G | p22-0616sc13g.htm | 0000902664-22-001707 | 005-92700 | 22631219 | 34 | 43673 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-040482 | 005-92700 | 22627470 | 34 | 213241 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001104659-22-021924 | 005-92700 | 22626299 | 34 | 93214 | |||
| 2022-02-10 | SC 13G | SC 13G | 0001193125-22-034689 | 005-92700 | 22615436 | 34 | 79603 | |||
| 2022-02-04 | SC 13G | us89854m1018_020422.txt | 0000834237-22-007356 | 005-92700 | 22593610 | 34 | 12940 | |||
| 2022-01-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-015468 | 001-40603 | 22547550 | 34 | 168649 | 1 | 1 |
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-002654 | 5427 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-002651 | 5420 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-002650 | 5425 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-002647 | 5445 | ||||||
| 2022-01-20 | 4 | FORM 4 SUBMISSION | 0000899243-22-002646 | 5418 | ||||||
| 2021-12-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-049764 | 7196 | ||||||
| 2021-12-02 | 8-K | 8-K | 1.01,2.03,9.01 | 0000950170-21-004987 | 001-40603 | 211464955 | 34 | 1154125 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-003918 | 001-40603 | 211394414 | 34 | 6871851 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003893 | 001-40603 | 211394347 | 34 | 384770 | 1 | 1 |
| 2021-09-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-037802 | 5055 | ||||||
| 2021-09-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-037149 | 5060 | ||||||
| 2021-09-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-037147 | 6584 | ||||||
| 2021-09-13 | 4 | FORM 4 SUBMISSION | 0000899243-21-035684 | 5059 | ||||||
| 2021-09-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-035470 | 5459 | ||||||
| 2021-09-09 | 3 | FORM 3 SUBMISSION | 0000899243-21-035469 | 2905 | ||||||
| 2021-09-09 | 4 | FORM 4 SUBMISSION | 0000899243-21-035442 | 5081 | ||||||
| 2021-08-31 | 4 | FORM 4 SUBMISSION | 0000899243-21-034610 | 5064 | ||||||
| 2021-08-19 | 10-Q | 10-Q | 0001564590-21-045079 | 001-40603 | 211188397 | 34 | 6834226 | 1 | 1 | |
| 2021-08-19 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-045076 | 001-40603 | 211188388 | 34 | 266167 | ||
| 2021-07-28 | SC 13G | SC 13G | 0001104659-21-096975 | 005-92700 | 211122890 | 34 | 84104 | |||
| 2021-07-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-029479 | 16100 | ||||||
| 2021-07-22 | SC 13D | SC 13D | 0001104659-21-094915 | 005-92700 | 211107845 | 34 | 145843 | |||
| 2021-07-22 | 4 | PRIMARY DOCUMENT | 0001638599-21-000606 | 31448 | ||||||
| 2021-07-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-029440 | 7000 | ||||||
| 2021-07-22 | 4 | FORM 4 SUBMISSION | 0000899243-21-029437 | 4652 | ||||||
| 2021-07-20 | 8-K | 8-K | 5.02,5.03,9.01 | 0001193125-21-219696 | 001-40603 | 211101548 | 34 | 217843 | ||
| 2021-07-19 | 424B4 | 424B4 | 0001193125-21-218024 | 333-255491 | 211096838 | 33 | 7561934 | |||
| 2021-07-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-028652 | 5703 | ||||||
| 2021-07-16 | 4 | FORM 4 SUBMISSION | 0000899243-21-028648 | 7661 | ||||||
| 2021-07-16 | S-8 | S-8 | 0001193125-21-216925 | 333-257941 | 211094256 | 33 | 218469 | |||
| 2021-07-16 | FWP | FWP | 0001193125-21-216710 | 333-255491 | 211093918 | 34 | 9752 | |||
| 2021-07-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-07-15 16:00:00 | 9999999995-21-002781 | 333-255491 | 211094196 | 33 | 1681 | ||
| 2021-07-15 | S-1MEF | S-1MEF | 0001193125-21-216744 | 333-257938 | 211094159 | 33 | 55551 | |||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028526 | 8668 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028525 | 4256 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028523 | 2841 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028522 | 6679 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028519 | 9097 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028517 | 4243 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028516 | 7639 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028513 | 2832 | ||||||
| 2021-07-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-028512 | 4165 | ||||||
| 2021-07-15 | 3 | PRIMARY DOCUMENT | 0001638599-21-000603 | 18117 | ||||||
| 2021-07-15 | 3 | PRIMARY DOCUMENT | 0001638599-21-000602 | 2849 | ||||||
| 2021-07-15 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004135 | 271769 | ||||||
| 2021-07-15 | CERT | 8A_Cert_TCRX.pdf | 0001354457-21-000796 | 001-40603 | 211091975 | 34 | 583035 | |||
| 2021-07-14 | CORRESP | filename1.htm | 0001193125-21-215243 | 19820 | ||||||
| 2021-07-13 | UPLOAD | filename1.pdf | 0000000000-21-008658 | 44018 | ||||||
| 2021-07-13 | 8-A12B | 8-A12B | 0001193125-21-214090 | 001-40603 | 211087937 | 34 | 14011 | |||
| 2021-07-13 | CORRESP | filename1.htm | 0001193125-21-213952 | 10384 | ||||||
| 2021-07-13 | CORRESP | filename1.htm | 0001193125-21-213949 | 10002 | ||||||
| 2021-07-12 | S-1/A | S-1/A | 0001193125-21-212364 | 333-255491 | 211084189 | 33 | 7425919 | |||
| 2021-05-14 | S-1/A | S-1/A | 0001193125-21-161996 | 333-255491 | 21924561 | 33 | 7439730 | |||
| 2021-05-05 | CORRESP | filename1.htm | 0001193125-21-151730 | 17946 | ||||||
| 2021-05-05 | S-1/A | S-1/A | 0001193125-21-151721 | 333-255491 | 21893372 | 33 | 248628 | |||
| 2021-05-03 | UPLOAD | filename1.pdf | 0000000000-21-005643 | 44672 | ||||||
| 2021-04-30 | CORRESP | filename1.htm | 0001193125-21-145468 | 31216 | ||||||
| 2021-04-30 | S-1/A | S-1/A | 0001193125-21-145429 | 333-255491 | 21879314 | 33 | 7260325 | |||
| 2021-04-30 | CORRESP | filename1.htm | 0001193125-21-143774 | 108963 | ||||||
| 2021-04-29 | UPLOAD | filename1.pdf | 0000000000-21-005435 | 49961 | ||||||
| 2021-04-28 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-002242 | 272404 | ||||||
| 2021-04-23 | CORRESP | filename1.htm | 0001193125-21-129279 | 72347 | ||||||
| 2021-04-23 | S-1 | S-1 | 0001193125-21-129264 | 333-255491 | 21850659 | 33 | 10025039 | |||
| 2021-04-15 | UPLOAD | filename1.pdf | 0000000000-21-004581 | 69832 | ||||||
| 2021-04-12 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001727 | 276699 | ||||||
| 2021-03-19 | DRS | filename1.htm | 0000950123-21-003678 | 377-04469 | 21759163 | 33 | 7414462 | |||
| 2021-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001783328-21-000001 | 021-387638 | 21562362 | 33 | 11671 | ||
| 2019-07-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001783328-19-000001 | 021-345133 | 19976745 | 33 | 11796 |
One latest value per concept from companyfacts (190 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 23.98M | 2022-03-04 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 56.87M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 31.93M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-040961 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 12.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 765,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 21.57M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 51,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 634.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | USD | 14.75M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.08M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 158.07M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 11.71M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 19.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | Assets | Assets | USD | 141.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 76.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 68.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 52,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 73.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 78.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -79.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 92.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 165.21M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 1.68M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 1.42M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -92.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 14.75M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 7.06M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 34.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | DebtInstrumentInterestRateDuringPeriod | Debt Instrument, Interest Rate During Period | pure | 0.126 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124575 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 1.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 400,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 2.54M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 2.50M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 2.62M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 1.25M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 716,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 177.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 48.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 13.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 32.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.32M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 161.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 75,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | Depreciation | Depreciation | USD | 2.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 2.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.67 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009472 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.225 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.017 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.009 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.075 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.05 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 6.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 18.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009472 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009472 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -99,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -1.09M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 24.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 29.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -27.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 19,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 3.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 31.93M | 2023-01-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095066 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 5.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -2.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 38,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | IncreaseDecreaseInPrepaidRent | Increase (Decrease) in Prepaid Rent | USD | 2.17M | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061533 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 2.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | InterestExpense | Interest Expense | USD | 2.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | InterestExpenseLongTermDebt | Interest Expense, Long-term Debt | USD | 2.90M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124575 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 11,000 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-19 | 0001564590-21-045079 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 1.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 190,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 18.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.099 | 2022-10-28 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006589 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 83.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 12.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 184,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 13.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 13.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 13.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 22.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | Liabilities | Liabilities | USD | 103.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 141.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 37.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 32.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 15.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 16.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 12.19M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-275933 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 12.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 12.19M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001193125-26-207572 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 13.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 4.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 17.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 111.42M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 99,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -576,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -78.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -92.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -47.50M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023507 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 95.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -92.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 13.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 61.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 8.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 48.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 10.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 52.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.08 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 174.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 190,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-345749 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 135,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 553,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 2.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PaymentsForTenantImprovements | Payments for Tenant Improvements | USD | 3.80M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023507 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 324,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0000950170-24-026875 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 200,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 87.47M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 604,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-275933 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 3.76M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023507 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 89.65M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006589 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 33.10M | 2024-04-24 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 99.73M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006589 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 29.35M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-06 | 0000950170-24-026875 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 29.80M | 2024-12-27 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 32.46M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 186.25M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.72M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 99,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001193125-26-345749 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -92.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 30.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 7.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 17.14M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 70.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 5.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | Role | 66 | 2025-11-03 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.75 | 2026-09-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 3.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -596.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 2.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 6.13M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 4.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 6.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.96 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.044 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1.95M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.19 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 44,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-05 | 0000950170-25-033077 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 38.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 8.2 | 2021-05-13 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-003918 | |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 99,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 33.13M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1.72M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 59.68M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 68.88M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 57.92M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-09 | 0000950170-22-003175 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 39.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 5.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-04 | 0001193125-26-089884 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 129.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 23.97M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009472 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 129.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456919 |